サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：手根管開放システムの世界市場-2023年～2030年
市場調査レポート
商品コード
1374889

手根管開放システムの世界市場-2023年～2030年

Global Carpal Tunnel Release System Market - 2023-2030

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
手根管開放システムの世界市場-2023年～2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

手根管開放システムは、手根管症候群（CTS）を治療するための医療処置であり、一連の技術です。CTSは、前腕から手にかけて走る正中神経が、手首の手根管と呼ばれる狭い通路を通る際に圧迫されたり、圧迫されたりすることで頻繁に起こる症状です。

手根管症候群（CTS）の治療には主に2つの外科的アプローチがあり、観血的手根管開放システムと内視鏡的手根管開放システムです。さらに、手根管症候群の有病率の増加、手根管開放や腱症の治療に対する新しいアプローチ、市場プレイヤーによる医学教育トレーニングプログラムの増加が、予測期間中に市場を牽引すると予想される要因です。

ダイナミクス

手根管開放と腱鞘炎治療への新たなアプローチが市場成長を促進する見込み

手根管症候群の患者は、しばしば腱症を経験します。手根管開放システムは最近、手根管の開放に加えて腱症にも対処できるように改良されています。例えば、メイヨークリニックは、手根管開放のための超音波ガイド下介入を提供する数少ないハンドセンターのひとつであり、これは先進的な治療法です。Thread Ultrasound-Guided Carpal Tunnel Release（TCTR）は、大きな切開を必要としない、低侵襲の新しい手技です。従来の観血的手根管開放システムに比べ、周辺組織へのダメージが大幅に軽減されるため、術後の痛みが少なく、回復も早くなります。

超音波ガイドの使用はTCTRの重要な側面です。この技術により、外科医は手根管の内部構造をリアルタイムで見ることができ、研磨糸を正確かつ精密に配置することができます。その結果、周囲の構造物に危害を与えるリスクが減少し、手術はより効果的で安全なものとなります。

さらに、TCTRは通常外来で行われるため、患者は手術当日に帰宅することができます。これは患者の利便性を高めるだけでなく、医療費の削減にもつながります。TCTRは従来のCTRよりも侵襲が少ないため、患者の回復が早まる可能性があります。これにより、多くの人が日常生活を早期に再開でき、術後のリハビリの回数も少なくて済む可能性があります。

したがって、この手技がより普及し洗練されれば、手根管開放システムの研究や技術革新に影響を与え、手技や技術のさらなる向上につながる可能性があります。このように、上記の要因から、予測期間中、市場は拡大すると予想されます。

手根管開放システムの高コストが市場成長の妨げになる見込み

手根管開放システム、特にMicroaire 81014のような低侵襲性システムのコストは2,500ドル前後と非常に高いです。このコストの高さは、患者と医療施設の双方にとって大きな問題となります。多くの患者は、高額な費用のために手根管症候群の治療を受けることを躊躇しており、その結果、痛みや障害が長引く可能性があります。

さらに、予算が限られている地域の医療施設では、このような高価なシステムを購入できない可能性があり、高度な手根管開放システムへのアクセスが制限されます。そのため、これらのシステムに関連する高コストが市場浸透の低下や普及の妨げとなり、最終的には影響を受ける地域の患者ケアや医療インフラに影響を及ぼしています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 手根管開放と腱鞘炎治療の新しいアプローチ
      • 市場参入企業による医療教育トレーニングプログラムの増加
    • 抑制要因
      • 手根管開放システムの高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • パイプライン分析
  • 特許分析
  • DMIオピニオン

第6章 COVID-19分析

第7章 製品タイプ別

  • 開放型手根管開放システム
  • 内視鏡的手根管開放システム

第8章 手術アプローチ別

  • 低侵襲手術
  • 観血手術

第9章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Arthrex, Inc.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • MicroAire Surgical Instruments, LLC
  • Trice Medical
  • Smith & Nephew plc
  • Integra LifeSciences Corporation
  • Stryker Corporation
  • Innomed, Inc.
  • A.M. Surgical, Inc.
  • Medical Designs, LLC
  • Sonex Health Inc.

第13章 付録

目次
Product Code: MD7186

Overview

Carpal tunnel release system is a medical procedure and a set of techniques that are used to treat carpal tunnel syndrome (CTS). CTS is a frequently occurring condition in which the median nerve, running from the forearm into the hand, gets compressed or squeezed as it passes through a narrow passageway called the carpal tunnel in the wrist.

There are two main surgical approaches used to treat carpal tunnel syndrome (CTS) open carpal tunnel release system and endoscopic carpal tunnel release system. Furthermore, the increasing prevalence of carpal tunnel syndrome, new approaches to carpal tunnel release and treatment of tendinopathy, and rising medical education training programs by the market players are the factors expected to drive the market over the forecast period.

Dynamics

New Approaches to Carpal Tunnel Release and Treatment of Tendinopathy is Expected to Drive Market Growth

Patients with carpal tunnel syndrome often experience tendinopathy, a common condition. Carpal tunnel release systems have recently been improved to address tendinopathy in addition to releasing the carpal tunnel. For instance, the Mayo Clinic is one of the few hand centers that provide ultrasound-guided intervention for carpal tunnel release, which is an advanced treatment. Thread Ultrasound-Guided Carpal Tunnel Release (TCTR) is a newer, minimally invasive technique that does not require large incisions. Compared to traditional open CTR procedures, this approach significantly reduces the damage to the surrounding tissues, resulting in less postoperative pain and faster recovery times for patients.

The use of ultrasound guidance is a crucial aspect of TCTR. This technology enables surgeons to view the internal structures of the carpal tunnel in real time, ensuring accurate and precise placement of the abrasive thread. As a result, the risk of harm to surrounding structures is reduced, and the procedure becomes more effective and safe.

In addition, TCTR is usually done on an outpatient basis, allowing patients to return home on the same day of the operation. This not only increases patient convenience but also results in reduced healthcare expenses. TCTR is a less invasive alternative to traditional CTR, which means that recovery times may be faster for patients. This can enable many individuals to resume their daily activities earlier and potentially require less postoperative rehabilitation.

Therefore, the procedure becomes more widespread and refined, it may influence research and innovation in carpal tunnel release, leading to further improvements in techniques and technologies. Thus, owing to the above factors, the market is expected to drive over the forecast period.

High Cost of Carpal Tunnel Release System is Expected to Hamper the Market Growth

The cost of carpal tunnel release systems, especially minimally invasive ones like the Microaire 81014, is very high around $2,500. This high cost poses a significant problem for both patients and healthcare facilities. Many patients are deterred from seeking treatment for carpal tunnel syndrome due to the high cost, which can lead to prolonged pain and disability.

Additionally, healthcare facilities in regions with limited budgets may not be able to afford these expensive systems, which limits access to advanced carpal tunnel release techniques. Therefore, the high costs associated with these systems have led to reduced market penetration and hindered their widespread adoption, ultimately impacting patient care and healthcare infrastructure in affected regions.

Segment Analysis

The global carpal tunnel release system market is segmented based on product type, surgical approach, technology, end-user and region.

The Endoscopic Carpal Tunnel Release Systems from the Product Type Segment Accounted for Approximately 56.3% of the Carpal Tunnel Release System Market Share

Carpal tunnel syndrome is a common condition where the median nerve in the wrist is compressed and causes discomfort. Endoscopic Carpal Tunnel Release Systems (ECTRS) are minimally invasive surgical tools designed to treat this condition. ECTRS involves the use of a small endoscope, which is a thin tube with a camera, and specialized instruments to release the transverse carpal ligament. This procedure helps to alleviate the pressure on the median nerve and provides relief from the symptoms of carpal tunnel syndrome.

Moreover, it leads to smaller incisions, reduced post-operative pain, faster recovery times, and less scarring when compared to traditional open surgery. ECTRS also enables patients to return to their daily activities and work more quickly, making it a more appealing choice for those searching for a faster and less disruptive remedy for carpal tunnel syndrome.

In addition, ECTRS enables patients to return to their daily activities and work sooner, making it an attractive option for individuals seeking a faster and less disruptive treatment for carpal tunnel syndrome. Furthermore, increasing preference for minimally invasive procedures, increasing the prevalence of carpal tunnel syndrome, and technological advancements are the factors expected to drive the market segment over the forecast period.

For instance, the traditional method for treating this condition involved open surgery, which required a larger incision in the wrist to access and release the compressed median nerve. However, with the advancement of minimally invasive techniques, endoscopic carpal tunnel release has become more popular.

The Endotrac Endoscopic Carpal Tunnel Release System by Stryker is a medical device that enables minimally invasive surgical treatment of carpal tunnel syndrome, a common condition where the median nerve in the wrist is compressed.

Therefore, endoscopic carpal tunnel release systems have gained more popularity among patients and healthcare providers as compared to traditional open surgery in treating carpal tunnel syndrome. This trend reflects the broader shift in medicine toward minimally invasive procedures whenever feasible, as they tend to offer better patient outcomes and experiences. Hence, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Penetration

North America Accounted for Approximately 39.2% of the Market Share in 2022

North America region is expected to hold the largest market share over the forecast period owing to the increasing prevalence of carpal tunnel syndrome, increasing adoption of surgical intervention, the introduction of new products, and rising healthcare expenditure.

For instance, according to the Mayo Foundation for Medical Education and Research (MFMER) Article, Carpal tunnel syndrome is a common condition that affects many people, and it is estimated that 71% of patients undergo surgical intervention as their primary treatment.

The cost of medical care for carpal tunnel syndrome in the United States is approximately $2 billion per year, and the median time lost from work is just under 30 days. The surgical treatment usually involves an open procedure, while the endoscopic approach is often associated with less postoperative pain and a faster return to work.

Competitive Landscape

The major global players in the carpal tunnel release system market include: Arthrex, Inc., MicroAire Surgical Instruments, LLC, Trice Medical, Smith & Nephew plc, Integra LifeSciences Corporation, Stryker Corporation, Innomed, Inc., A.M. Surgical, Inc., Medical Designs, LLC, and Sonex Health Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has negatively impacted the carpal tunnel release system market. Due to the COVID-19 pandemic, healthcare facilities have been focusing their resources on treating infected patients while trying to limit the spread of the virus. As a result, many elective surgeries, such as carpal tunnel release procedures, have been postponed or canceled. This temporary delay in surgeries has caused a decline in demand for carpal tunnel release systems.

The pandemic has caused a prominent rise in remote consultations and telemedicine. Therefore, some patients with mild to moderate carpal tunnel syndrome might have chosen non-surgical treatments and remote consultations instead of surgery, which could have impacted the demand for carpal tunnel release systems. The pandemic has also highlighted the significance of safety in healthcare settings. This focus on safety may have accelerated the adoption of minimally invasive techniques such as endoscopic carpal tunnel release systems, which provide advantages such as reduced hospital stays and faster recovery times.

By Product Type

  • Open Carpal Tunnel Release Systems
  • Endoscopic Carpal Tunnel Release Systems

By Surgical Approach

  • Minimally Invasive
  • Open Surgery

By End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Specialty Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On August 9, 2022, Sonex Health and The Institute of Advanced Ultrasound Guided Procedures enrolled first patient in the trial of ultrasound guided Carpal Tunnel Release (CTR) versus Traditional Open Release (TUTOR) the first multicenter randomized controlled trial in the United States to compare the efficacy and safety of traditional mini-open carpal tunnel release (mOCTR) and carpal tunnel release using the FDA-cleared UltraGuideCTR and real-time ultrasound guidance.

Why Purchase the Report?

  • To visualize the global carpal tunnel release system market segmentation based on product type, surgical approach, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of carpal tunnel release system market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global carpal tunnel release system market report would provide approximately 61 tables, 56 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Surgical Approach
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. New Approaches to Carpal Tunnel Release and Treatment of Tendinopathy
      • 4.1.1.2. Rising Medical Education Training Program by the Market Players
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Carpal Tunnel Release System
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Pipeline Analysis
  • 5.6. Patent Analysis
  • 5.7. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Open Carpal Tunnel Release Systems*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Endoscopic Carpal Tunnel Release Systems

8. By Surgical Approach

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
    • 8.1.2. Market Attractiveness Index, By Surgical Approach
  • 8.2. Minimally Invasive*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Open Surgery

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centres
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Arthrex, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. MicroAire Surgical Instruments, LLC
  • 12.3. Trice Medical
  • 12.4. Smith & Nephew plc
  • 12.5. Integra LifeSciences Corporation
  • 12.6. Stryker Corporation
  • 12.7. Innomed, Inc.
  • 12.8. A.M. Surgical, Inc.
  • 12.9. Medical Designs, LLC
  • 12.10. Sonex Health Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us